Comparison

CCG-203971

Item no. V3118-500mg
Manufacturer InvivoChem LLC
CASRN 1443437-74-8
Amount 500 mg
Quantity options 100 mg 10 mg 1 g 250 mg 25 mg 50 mg
Category
Type Biochemicals
Specific against other
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Available
Description
InvivoChem Cat #:V3118CAS #:1443437-74-8 Purity >=98%

Description: CCG-203971 is a novel, 2nd generation small-molecule inhibitor of the Rho/MRTF/SRF RhoA/myocardin-related transcription factor A (MRTF-A) pathway with an IC50 value of 0.64 uM for SRE. CCG-203971 inhibits expression of connective tissue growth factor (CTGF), alpha-smooth muscle actin (alpha-SMA), and collagen 1 (COL1A2) in both SSc fibroblasts and in lysophosphatidic acid (LPA)-and transforming growth factor beta (TGFbeta)-stimulated fibroblasts. CCG-203971 significantly represses TGF-beta- induced MKL1 expression at 25 uM concentration.

Description:

References: 2014 Jun; 349(3):480-6; 2017 Apr 15; 27(8):1744-1749.

References:
Molecular Weight (MW)
408.88
Formula
C23H21ClN2O3
CAS No.
1443437-74-8
Storage
-20C for 3 years in powder form
-80C for 2 years in solvent
Solubility (In vitro)
DMSO: 81 mg/mL (198.1 mM)
Water: < 1mg/mL
Ethanol: 4 mg/mL (9.8 mM)
Solubility (In vivo)
10% DMSO : 40% PEG300 : 5% Tween-80 : 45% saline: >= 2.5 mg/mL
Synonyms
CCG203971; CCG 203971; CCG-203971.
SMILES Code
O=C(C1CN(C(C2=CC=CC(C3=CC=CO3)=C2)=O)CCC1)NC4=CC=C(Cl)C=C4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close